CBS News
U.S. regulators have approved the first drug aimed at women with advanced breast cancer caused by an inherited flawed gene. The Food and Drug Administration on Friday approved AstraZeneca PLC’s Lynparza for patients with inherited BRCA gene mutations
Breast cancer survival ‘unaffected by faulty gene’BBC News
FDA approves first treatment for breast cancer with a certain inherited genetic mutationFDA.gov
US OKs 1st Drug Aimed at Women With Inherited Breast CancerU.S. News & World Report
WebMD -Washington Post -Cancer Network -GenomeWeb
all 74 news articles …read more

Source: HEALTH